The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

Hims & Hers (HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk (NVO) announced a partnership with ...

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...

The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of ...

Unprofitable today, with $53.5 million in trailing-12-month losses and about $39 million in annual cash burn, Nano-X is the ...

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019.

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and even a stall in research and development.

WPTV is diving into the proposed creation by Robert F. Kennedy Jr., the U.S. Secretary of Health and Human Services, for a ...

Coca-Cola Stock Gains as Earnings Beat. Tariffs Will Be ‘Manageable.’ ...